ArticleFrontiers in immunology2025

Development of a novel prognostic score for 1-year survival in immunotherapy-treated patients with unresectable HCC: the ALIVE-IO score.

Spyridon Pantzios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.